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A B S T R A C T
Prostate specific antigen (PSA) is a widely used marker for the diagnosis of prostate cancer, and the increasing
attention has been attracted on the development of rapid assay using biosensing technology. However, it remains
challenging for the sensitive and selective detection of PSA in clinical samples. Here, we report a label-free
microfluidic paper-based analytical device for highly sensitive electrochemical detection of PSA. The paper
device was fabricated with wax printing to generate hydrophobic and hydrophilic layers for the construction of
microfluidic channel, followed by screen-printing of three electrodes including working, counter and reference
electrode. Gold nanoparticles (AuNPs)/reduced graphene oxide (rGO)/thionine (THI) nano composites were
synthesized and characterized, which were coated onto working electrodes for the immobilization of DNA ap-
tamer probe. THI servers as the electrochemical mediator to transduce the biological recognition between DNA
aptamer and PSA, and the excellent conductivity of AuNPs and rGO also play a significant role of electron
transfer, leading to a sensitive detection for PSA, able to detect PSA as low as 10 pgmL−1, with a linear range
from 0.05 to 200 ngmL−1. We demonstrated that our electrochemical sensor for the detection of clinical serum
samples, indicating that our sensor would provide a new platform for low cost, sensitive and point-of-care
diagnosis of prostate cancer.
1. Introduction
Cancer is the major cause for the deaths worldwide (Siegel et al.,
2017), and prostate cancer that targets the prostate gland, is a third
leading cause of cancer mortality in men (Nelson et al., 2003). How-
ever, currently there are still no effective cures for the advanced me-
tastatic stage of prostate cancer (Vassilikos et al., 2000; Huang et al.,
2006; Geifman and Butte, 2016). Early and accurate diagnosis can in-
crease the chances of successful treatment, which also provide the
possibility to prolong the survival time (Mahal et al., 2016). Prostate
specific antigen (PSA) is considered as the best serum biomarker
available for the early detection of prostate cancer (Chen et al., 2012;
Stock et al., 2015). The PSA level increases with advancing clinical
stage and is proportional to the estimated volume of the tumor (Xie
et al., 2016). In general, the level of PSA from 4 ngmL−1 in a human
serum sample is usually regarded as the cut-off value for potential di-
agnosis as prostate cancer (Yang et al., 2015). To this end, the ultra-
sensitive, highly selective and point-of-care detection of PSA is essential
for early cancer diagnosis (Grubisha et al., 2003; Spain et al., 2016).
Currently, the detection of PSA in the serum occurs at dedicated
centralized laboratories using a large automated analyzer (Khan et al.,
2018), requiring additional sample transportation, which is usually
time-consuming and costly (Mueller-Lisse et al., 2002). In the past few
years, a lot of methods such as enzyme-linked immunosorbent assay
(ELISA) (Murphy et al., 2010), time-resolved fluorescence assay (Härmä
et al., 2015), chemiluminescence immunoassay (Zhang et al., 2008; Liu,
Fang et al., 2016), bioluminescent immunoassay (Ito et al., 2007) and
electrochemical immunoassay (Jolly et al., 2016) have been developed
for the detection of PSA based on the immunoreaction in a tedious and
expensive way. On the contrary, the development of a biosensors for
PSA detection will offers a great possibility for creating a low-cost and
highly sensitive point-of-care testing (POCT) of PSA in real time (Healy
et al., 2007). This would also drastically decrease the need for sample
transportation to the central laboratories, which is very helpful to build
a new economic way for healthcare system (Lilja et al., 2008). Com-
pared to other methods, the electrochemical sensors have shown great
advantages, such as fast response time, low cost, and less or minimal
sample processing (Li et al., 2014).
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Most of the detection methods for PSA are based on antibodies due
to their high selectivity toward the antigen (Chen et al., 2014). How-
ever, antibodies are larger molecules and have greater peptidase sus-
ceptibility and immunogenicity, which may limit its applications
(Murphy et al., 2015). Compared with antibodies, nucleic-acid apta-
mers, which are selected by a technology called SELEX (Systematic
Evolution of Ligands by Exponential Enrichment) in vitro, have recently
attracted more and more attention, due to low cost, stability and being
easy to synthesize (Keefe and Cload, 2008; Sefah et al., 2010). Their
well-defined structures enable their efficient recognition with the tar-
gets, including small molecules, peptides and proteins, with an ex-
cellent affinity and specificity. More importantly, they would offer re-
markable flexibility and convenience in the design of their structures,
which has led to higher sensitivity and selectivity for the development
of novel biosensors (Savory et al., 2011). It is easy to modify aptamers
chemically with plenty of functional groups, such as biotin, amine and
thiol groups on its 5′ end, enabling for the immobilization of probes for
the biosensors chip (Ohno et al., 2010).
Paper is a biocompatible porous cellulose fiber web with large
surface area, and the porous nature fulfills the primary tasks such as
diagnostic tests using body fluids and fluid transport (Liana et al., 2012;
Nery et al., 2013). Since microfluidic paper-based analytical devices
(μPADs) were first reported by Whitesides’ group, they were increas-
ingly recognized as ideal platforms designed for POCT (Martinez et al.,
2010). μPADs have demonstrated excellent properties, including low
sample and reagent consumption, low cost, small size, portable and
easy-to-operate. What's more, μPADs can be fabricated in bulk using
less expensive means, including photolithography, inkjet etching and
printing (Li et al., 2013). Among various methods, wax-printing is
considered as the cheapest and most easily implemented means of mass
production available, and has recently been shown to be very effective
in the production of PADs at minute cost (X. Wang et al., 2016; Y. Wang
et al., 2016).
Nanotechnology is playing a significant role in fabrication of sen-
sitive biosensors. Currently, more and more nanomaterials have been
developed to improve the sensitivity and specificity of target detection
(Wang et al., 2018). Compared with traditional sensors, nanomaterials
modified electrochemical biosensors not only possessed large surface
area and favorable microenvironment, but also exhibited remarkable
conductivity, stability and excellent biocompatibility (Yang et al.,
2017). For example, graphene, a two-dimensional nano carbon material
with extraordinary physical and chemical properties, has been one of
the most promising materials in designing electrochemical biosensors
(X. Wang et al., 2016; Y. Wang et al., 2016). Besides, gold nanoparticles
(AuNPs), one of the metallic nanoparticles, possess large specific sur-
face area, good biocompatibility and high surface free energy. They are
able to be bond with functional groups such as amino group (–NH2) and
mercapto group (–SH) (Ding et al., 2017). Moreover, the nanohybrids of
graphene with gold nanostructure has combined all the advanced
properties and/or even enhanced the performance for the sensing due
to the synergetic interaction. For example, the nanohybrids can not
only efficiently immobilize the biological receptor but also limit the
non-specific adsorption, which will significantly improve the sensitivity
of biosensors (Singh and Singh, 2013).
In this paper, we proposed a low cost, label-free, highly sensitive
and selective electrochemical aptamer sensor to detect PSA in serum
samples using disposable paper microfluidic device. We fabricate the
paper-based sensor with wax-printing and screen-printing. The AuNPs/
rGO/THI were synthesized and well characterized for the surface
modification of paper electrodes. DNA aptamer was immobilized onto
the nanomaterial coated paper electrodes for the specifically recogni-
tion of PSA. We optimized the condition to sensitively detect PSA as low
as 10 pgmL-1, also enabling the detection of the clinical serum samples.
Experimental results demonstrated that our electrochemical sensors
had a great potential for the detection of clinical sample in a rapid and
low-cost way and our sensors could be used as POCT for cancer
diagnosis.
2. Experimental section
2.1. Apparatus
The Gamry electrochemical potentiostat was used to carry out
electrochemical measurements, including differential pulse voltam-
metry (DPV) and cyclic voltammetry (CV) (Gamry Reference 600,
Gamry Instruments, Warminster, PA, USA). A three-electrode system
was integrated into the microfluidic paper-based device. Deionized
water was purified through a Michem ultrapure water apparatus
(Michem, Chengdu, China, resistivity> 18MΩ cm-1). The morphology
of composites was characterized by A JEOL-100CX transmission elec-
tron microscope (TEM) (H7650, Hitachi, Japan). A Xerox ColorQube
8570 digital wax printer was used to spray wax on the surface of paper.
Other apparatus in this study included oven from Yiheng (DHG-9023A,
Yiheng, Shanghai, China) and ultrasonic generator from Hechuang
(China).
2.2. Reagents
DNA aptamer against PSA: 5′-ATT AAA GCT CGC CAT CAA ATA GC-
3′ (Mw 7196.85 gmol-1) were synthesized and purified by Sangon
Biotechnology Co. Ltd. (Shanghai, China). In addition, anti-PSA
apatmer was modified with a thiol group to be immobilized onto
electrodes for DPV measurement. PSA and Tris-
Ethylenediaminetetraacetic acid (EDTA) buffer solution (10 mMTris-
HCl + 1mM EDTA, pH=8.0) were purchased from Shanghai Sangon
Biotechnology Co. Ltd. Thionine acetate was purchased from Alfa
Aesar. 6-mercaptohexanol (MCH) was provided by Sigma-Aldrich
(USA). Reduced graphene oxide (rGO) was bought from Xianfeng
Nanomaterials Company (Nanjing, China). Whatman chromatography
paper NO. 1 (pure cellulose paper) was obtained from GE Healthcare
Worldwide and used with further adjustment of size. The conductive
carbon ink (ED581ss) was received from Acheson and Ag|AgCl ink
(CNC-01) was from Yingman Nanotechnology Company. All other
chemicals were of reagent grade and used as received. All solutions
were prepared using deionized water. Clinical serum samples were
provided by Beijing Shijitan Hospital, Capital Medical University
(Beijing, China).
2.3. Fabrication of the paper-based electrodes
A simple illustration of the microfluidic paper-based analytical de-
vice was shown in Scheme 1. The device, which consisted of two layers,
was fabricated on two pieces of cellulose filter papers. The specific size
of the device was 10.5 mm×30.0 mm. By adopting this size, the device
could be easily inserted into a backend interface and then a portable
electrochemical reader, enabling a rapid test even at low setting areas.
The workflow of the paper-based sensor was described as following, the
samples were introduced from the inlet, and then the filtered samples
flowed through the microchannel and were recognized by the DNA
aptamer on the electrodes. As paper is made of fibers and rich of porous
structures, the samples can permeate through the paper, reaching the
surface of the working electrode for the electrochemical detection.
The structures, including microfluidic channels and electrodes were
designed by the Adobe Illustrator CS5 software. During design, some
factors were taken into consideration, such as detection convenience
and so on. The designed patterns were shown in Scheme 1. As we can
see, the counter electrode and the reference electrode were in one layer.
They were grouped together, forming a circle in the middle, whose
diameter was 2mm. The working electrode was in another layer, whose
diameter is also 2mm. Besides, registration marks were designed on
each layer to ensure assembly accuracy.
After structural design, a Xexro digital wax printer was used to
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pattern the microfluidic channels onto the surface of cellulose fiber
papers (Scheme 1), and was heated at 140 °C for 1min, and the wax
would re-melt and penetrate into the porous filter paper to form the
hydrophobic areas with a double-sided pattern. However, the unpattern
white areas would still remain excellent hydrophilicity, thus forming
the microfluidic channels. Afterwards, we printed three electrodes onto
the surface of the above paper sheets by screen-printing technique. The
working electrode and the counter electrode were of conductive carbon
ink, while the reference electrode was of conductive Ag|AgCl ink,
which will be ready for the coating to perform electrochemical detec-
tion. The device could offer a number of advantages, such as a certain
amount of sample consumption, a small volume of required sample and
a simple procedure of sample handling.
2.4. Synthesis and characterization of AuNPs/rGO/THI nanocomposites
The synthesis of AuNPs/rGO/THI nanocomposite was formed due to
the π-π stacking interactions between benzene rings and the THI mo-
lecules, which contain benzene ring in their molecular structure and is
able to non-covalently attach to the rGO. Positively charged thionine
molecules enable negatively charged gold nanoparticles to bind with
the anionic rGO surfaces.
The rGO/THI nanocomposite was carried out in a 100mL round-
bottom flask equipped with a magnetic stirrer. Briefly, the protocol for
synthesizing the AuNPs/rGO/THI nanocomposite was described below:
a total of 10 mg of rGO was mixed with 10mL deionized water firstly
and treated with ultrasonic wave for 1 h to obtain rGO suspension. And
then 10mL of 2mgmL-1 THI solution was added to the above solution,
followed by string under high agitation speed at room temperature
overnight. The composites were centrifuged at 8000 rpm for 15min and
washed with deionized water to remove the non-integrated THI mole-
cules. The obtained rGO/THI nanocomposites were redispersed in 2mL
deionized water. Under vigorously stirring, 10mL of AuNPs solutions
were injected slowly. The resulting suspension was stirred for 12 h at
room temperature. The final mixture was centrifuged and purified,
followed by washing with ethanol and water for times. The synthesized
AuNPs/rGO/THI nanocomposites would be stored at 4 °C for further
use.
2.5. Elaboration of the electrochemical aptamer sensors
The fabrication procedure of the microfluidic paper-based apta-
sensor was shown in Scheme 1. Firstly, 10 μL AuNPs/rGO/THI
suspensions were transferred on the surface of the paper electrodes and
then dried in an oven at 50 °C for half an hour. Subsequently, 10 μL of
DNA aptamers solution was introduced onto the surface of AuNPs/rGO/
THI modified SPCE and incubated overnight at 4 °C. As the aptamers
had been modified with a thiol group, which is able to conjugate with
AuNPs on the electrode surface. The concentration of the aptamer was
optimized at 36 μgmL-1 to detect different concentrations of PSA. To
block any possible remaining active sites and reduce non-specific ad-
sorption, 10 μL of MCH solutions (1 mM) were added on the modified
electrode surface and incubated at room temperature for 1 h. After that,
the TE buffer (10mM Tris-HCl, 1 mM EDTA, pH 7.4) was utilized to
rinse the surface of the electrode, followed with storing at 4 °C for
further use. To access the function of the developed electrochemical
aptasensor, prior to electrochemical measurements, 10 μL of PSA solu-
tions at a designed concentration were added onto the electrode surface
to incubate for 1 h at room temperature.
2.6. Electrochemical measurements
All measurements used a three-electrode cell, with the nano-
composites modified SPCE as working electrode, the screen printed
carbon electrode as counter electrode and the screen printed Ag/AgCl
electrode as reference electrode, against which all potentials are
quoted. Three electrodes were integrated together into a single paper-
based aptasensor. Cyclic voltammetry (CV) and differential pulse vol-
tammetry (DPV) measurements were performed using a Gamry elec-
trochemical workstation in 0.1M PBS solutions (pH = 7.4). DPV scans
run between− 0.5 V and 0.3 V with settings of scan rate 0.05 V s-1, step
potential 0.005 V, modulation amplitude 0.05 V, modulation time
0.05 s and interval time 0.1 s. CV scans were conducted between −
0.5 V and 0.1 V, whose scan rate was 100mV s-1.
3. Results and discussion
3.1. Characterization of the paper electrodes surface
Fig. 1A illustrates TEM image of the synthesized rGO/THI nano-
composites and Fig. 1B shows the image of AuNPs/rGO/THI nano-
composites. Compared with rGO/THI nanocomposites, Fig. 1B confirms
that gold nanoparticles are typically hybridized with rGO surface with
dispersion. Free nanoparticles are nearly not present in the background
of TEM images, indicating their strong interactions with rGO. The THI
molecule, as an electrically active substance, is able to generate an
Scheme 1. Fabrication and modification process of the
microfluidic paper-based aptasensor and the typical re-
sponse of the detection of analyte (1) injection port; (2)
microfluidic channel; (3) reaction site; (4) screen-printed
carbon counter electrode; (5) screen-printed reference
electrodes; (6) working electrode; (7) screen-printed elec-
trode-lead.
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electric current through redox reactions on the surface of the electrode.
rGO, with favorable conductivity and biocompatibility, are usually
adopted to fabricate electrochemical biosensors for improving electro-
chemical signals. Moreover, they will also introduce nano-porous
structures to the surface of the electrode, which can remarkably in-
crease not only the surface area, but also the specific surface area, re-
sulting in a higher density load of electro-actively materials and a
higher electrochemical response. The catalytic activity of gold is known
to depend strongly on its size. Extremely small metal particles are of
tremendous interest due to their unusual catalytic and optical proper-
ties. In this work, AuNPs with an average diameter of 15 nm were used
for the hybridized, and it was anticipated not only to provide catalytic
activity when attached to rGO, but also help to chemically bond with
thiol groups modified aptamers.
3.2. Electrochemical responses of the paper-based aptasensor
In order to determine the basic electrochemical performance of the
designed paper-based analytical device, typical electrochemical mea-
surements including CV and DPV were performed. As shown in Fig. 2A,
CV responses of the bared working electrode, AuNPs/rGO/THI and
AuNPs/rGO/THI-aptamer modified electrodes were monitored in 0.1 M
PBS (pH = 7.4) at a scan rate of 100mV s−1. Compared with bared
electrode (black line), AuNPs/rGO/THI modified electrode (red line)
provide a pair of pronounced redox peaks, which was attributed to the
redox reactions of THI molecules on the surface of the electrode. The
position of peak currents of reduction and oxidation were nearly the
same though the electrodes were coated with different layers. The se-
paration of the corresponding potentials ΔEp were at about 59mV,
indicating a promising reversible electrochemical redox-reduction
process. The current response decreased after the introduction of DNA
aptamers onto the electrode (pink curve), demonstrating the im-
mobilization of aptamers through Au-S bond onto the electrodes sur-
face. This is likely that the binding of aptamers onto the electrodes
surface produced a steric hindrance, leading to a partial inhibition of
electron transfer. After the electrochemical aptasensor was incubated
with different concentrations of PSA, the peak currents further de-
creased. This may be associated with that the conjunction of DNA ap-
tamer and PSA resulted in the enhanced steric hindrance, which was
directly proportional to the concentrations of PSA, enabling to the
quantification of PSA with our electrochemical sensors. With an in-
creasing concentration of PSA, generating more aptamer-PSA complex,
the peak current decreased.
DPV responses of the electrodes were shown in Fig. 2B. Due to the
efficient redox-activity of THI and the excellent conductivity of rGO and
AuNPs, a peak current at 15.97 μA was present for the AuNPs/rGO/THI
nanocomposites modified aptasensor. Subsequently, the loading of ap-
tamers led to a decrease of the redox peak current owing to the for-
mation of a blocking layer for electron transfer. After incubated with a
solution of 100 pgmL-1 PSA, the insulating protein layers on the elec-
trode further prevent the electron transfer. The peak currents decreased
to 9.76 μA. This indicates that the difference of the current peak value is
Fig. 1. TEM images of (A) rGO/THI and (B) AuNPs/rGO/THI nanocomposites.
Fig. 2. Basic responses of the aptasensor monitored in 0.1M PBS solution, pH =7.4. (A) CV responses of the paper-based aptasensor: a) bare working electrode; b)
AuNPs/rGO/THI nanocomposites modified electrode; c) AuNPs/rGO/THI-aptamer modified electrode; d) the aptasensor incubated with 100 pgmL−1 PSA; e) the
aptasensor incubated with 1 ngmL−1 PSA; (B) DPV responses of the aptasensor: a) bare working electrode; b) AuNPs/rGO/THI nanocomposites modified electrode;
c) AuNPs/rGO/THI-aptamer modified electrode; d) the aptasensor incubated with 100 pgmL-1 of PSA.
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proportional to the concentration of PSA, enabling our proposed elec-
trochemical sensors to detect PSA. Additionally, the repeatability of the
aptasensor was also evaluated as it is a crucial parameter for disposable
paper sensors. As shown in Fig. S1, different sensors show similar
electrochemical response and the relative standard deviation from four-
time measurement was 1.06%, indicating our sensors have a promising
repeatability.
3.3. Detection of PSA with the paper-based electrochemical aptasensor
Under optimal experiments conditions, the analytical performance
such as sensitivity and dynamic range of the aptasensor for PSA de-
tection are evaluated in 0.1 M PBS solutions. The electrochemical ap-
tasensor was incubated with various concentrations of PSA, and
scanned by DPV. Each measurement was performed before the con-
jugation with PSA as the initial response. As shown in Fig. 3A, the
currents decreased gradually with the increasing PSA concentrations.
Based on the signal-to-noise ratio method using a factor of 3, the limit
of detection (LOD) was estimated to be 10 pgmL−1, and the dynamic
range was determined as from 0.05 ngmL−1 to 200 ngmL−1 (R2 =
0.995). The regression equation obtained between the currents and the
concentration of analytes was Idpv (μA) =7.6–2.0 lg CPSA (ngmL-1).
Typically, a PSA level of 4 ngmL−1 in a human serum sample is usually
regarded as the cut-off value for potential diagnosis of prostate cancer,
and our proposed paper sensor has an even lower LOD thus will provide
a promising tool for the detection of PSA in clinical sample for diag-
nosis.
In order to access the binding specificity of the aptasensor towards
PSA, some potential interference, including carcinoembryonic antigen
(CEA), neuron-specific enolase (NSE), ascorbic acid (AA), bovine serum
albumin (BSA) and immunoglobulin G (IgG) were tested for the eva-
luation of the selectivity. As shown in Fig. 4A, a significant decrease of
currents induced by the aptasensor with 1 ngmL-1 PSA, while the re-
sponses of the interfering proteins were nearly the same as the blank. It
was suggested that our electrochemical aptasensor had good specificity
towards PSA. In addition, another study was carried out in a mixture
condition to further explore the selectivity. 1 ngmL-1 of AA, IgG, NSE,
CEA and BSA were added separately into 1 ngmL-1 PSA solution. Even
though these interferences coexisted in the detection of PSA, the var-
iations of peak currents were 7.24%, 6.81%, 5.52%, 3.59% and 6.22%,
respectively, showing negligible changes. These data demonstrated that
our proposed paper-based aptasensor are very selective for PSA detec-
tion.
Table S1 summarized the analytical performance of the developed
sensors for the detection of PSA. Our electrochemical sensors show a
promising sensitivity and dynamic range. More importantly, our
electrodes were fabricated from paper, which is not only low cost,
disposable and easy-to-use, but also sensitive and selective for the de-
tection of protein cancer biomarkers such as PSA. Using conductive
nanomaterial for the surface modification of electrodes and a selective
and inexpensive DNA aptamer as the probe, we developed a label free
electrochemical sensor for the sensitive detection of PSA, enabling
rapid diagnosis of cancer and a wide biomedical application.
3.4. Analytical results of clinical serum samples
To further explore the feasibility of our aptasensor for clinical ap-
plications, human serum samples obtained from Shijitan Hospital were
analyzed. The results of clinical serum samples from our proposed
sensors were compared with reference values obtained by the electro-
chemiluminescence method (Roche, USA), which was performed in the
hospital as a standard way. Seven samples with known PSA con-
centration ranging from 2.1 ngmL-1 to 91.3 ngmL-1 were detected
firstly to obtain the linear fitting curve between the peak currents and
the concentrations of PSA (Fig. S2). As shown in Table 1, the clinical
serum samples were tested directly without any dilution and the ana-
lytical results were generally comparable with the reference values
tested in the hospital. The relative errors between this work and the
reference method are less than 8.81%, indicating that our aptasensors
hold a great promise for the detection of PSA in clinical samples.
4. Conclusion
In summary, we have demonstrated low cost and label-free elec-
trochemical aptamer sensors using paper microfluidic device for the
sensitive detection of PSA in clinical samples. We use the wax-printed
and screen-printing technology to fabricate the paper electrodes, and
modify the surface with electrochemical active nanomaterials for the
immobilization of aptamer probes for the highly sensitive and selective
detection of PSA. The excellent conductivity of AuNPs/rGO/THI mod-
ified electrodes enables an effective electron transfer at the interference
of the aptamer receptor and electrodes, inducing a specific peak current
associated with electrochemical mediator of THI. However, upon
binding with the analytes the decreasing of the peak current is pro-
portional to the concentration of the PSA, allowing for the quantifica-
tion of target. Under the optimized condition, our electrochemical ap-
tamer sensor is able to detect as low as 10 pgmL-1 of PSA, with a
dynamic range from 0.05 to 200 ngmL-1, allowing for the detection of
PSA in clinical samples. The testing of clinical serum samples shows a
reasonable variation with a standard reference from the hospital.
However, our sensors have a fast response time and low cost, providing
a potential tool for the POCT for cancer diagnosis. More importantly,
Fig. 3. (A) DPV responses to different concentrations of PSA in 0.1M PBS solution, pH=7.4; (B) The calibration curve of the paper-based electrochemical aptasensor
between the current peak and the various concentrations PSA.
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our aptamer sensors can also be used as a generic platform for the
detection of a range of analytes by adapting different aptamer probes,
such as small molecules and proteins for biomedical and environmental
application.
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Fig. 4. The evaluation of the selectivity of the proposed aptasensors (A) DPV responses of the sensor to 1 ngmL-1 PSA and 1 ngmL-1AA, IgG, NSE, CEA and BSA,
respectively; (B) DPV responses of the aptasensor to 1 ngmL-1 PSA and 1 ngmL-1 PSA mixed with 1 ngmL-1AA, IgG, NSE, CEA and BSA, respectively.
Table 1
Paper-based electrochemical aptamer sensors for the detection of PSA in clinical
serum samples.
No. Currents (μA) Reference (ngmL-
1)
This work (ngmL-
1)
Relative errors
(%)
1 6.72 1.12 1.03 − 8.04
2 6.65 3.06 2.91 − 4.90
3 6.57 4.72 4.85 2.75
4 6.54 5.15 5.48 6.41
5 6.49 7.17 6.65 − 7.25
6 6.45 8.08 7.73 − 4.33
7 6.40 9.06 8.89 − 1.88
8 6.32 10.50 11.05 5.24
9 6.34 11.13 10.58 − 4.94
10 6.24 12.12 12.97 7.01
11 6.27 12.79 12.18 − 4.77
12 6.19 13.12 14.28 8.84
13 6.16 14.57 15.08 3.50
14 6.15 15.45 15.13 − 2.07
15 6.10 17.31 16.47 − 4.85
16 5.93 20.42 20.76 1.67
17 5.78 25.13 24.34 − 3.14
18 5.12 38.92 40.69 4.55
19 4.34 61.43 60.22 − 1.97
20 4.12 70.24 65.55 − 6.68
21 3.75 78.72 74.85 − 4.92
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